• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant

Rimidi Partners with Quest Health to Improve Blood Glucose for Diabetes Patients via RPM

by Jasmine Pennic 06/18/2025 Leave a Comment

Rimidi Partners with Quest Health to Improve Blood Glucose for Diabetes Patients via RPM

What You Should Know:  - Quest Health Solutions, a national leader in diabetes care, today announced compelling results from its Remote Patient Monitoring (RPM) program, developed in partnership with the digital health company Rimidi. In just two months, the Quest Health RPM Services—powered by Rimidi's EHR-integrated platform—led to an 11% improvement in average blood glucose readings among participating patients. - The collaboration highlights the power of combining
Read More

Glytec Secures $36M to Advance AI-Powered Diabetes Care and Inpatient Glycemic Management

by Jasmine Pennic 06/18/2025 Leave a Comment

Glytec Secures $36M to Advance AI-Powered Diabetes Care and Inpatient Glycemic Management

What You Should Know:  - Glytec, a provider of an AI-powered technology platform for diabetes and related conditions, secures a $36M growth investment led by Savitr Capital and Hayfin Capital Management.  - The funding will fuel the continued expansion of Glytec’s platform, including its flagship Glucommander® SaaS solution, and accelerate the development of innovative new technologies. The investment comes as healthcare systems face increasing pressure to improve inpatient
Read More

Medtronic Rebrands Diabetes Business as “MiniMed” Ahead of Spin-Off

by Jasmine Pennic 06/13/2025 Leave a Comment

Medtronic to Separate Diabetes Business into New Standalone Company

What You Should Know:  - Medtronic announced that its planned New Diabetes Company will be named MiniMed. The name honors the company's roots, reflecting its original name prior to its acquisition by Medtronic in 2001 and its deep, 40-year history of transforming diabetes care worldwide. The announcement marks a significant step in the intended separation of Medtronic's Diabetes business into a new, independent entity. Simplify Life with Diabetes The new MiniMed's mission is to
Read More

Reach7 CEO Talks Reimagining Diabetes Care with Membership-Based Studio Clinics

by HIT Consultant Interviews 05/22/2025 Leave a Comment

Reach7 CEO Talks Transforming Diabetes Care with Membership-Based Studio Clinics

Today’s landscape of diabetes care is fraught with challenges: it's a condition that's often misunderstood by both patients and the healthcare system, highly prevalent, financially burdensome and frequently mismanaged. To explore a new paradigm in addressing these issues, we're speaking with Chun Yong, the founder and CEO of Reach7 Diabetes Studios. Chun, a biomedical engineer from Georgia Tech with experience as a UX strategist at Coca-Cola, is applying his unique expertise to "reimagine how
Read More

LifeMD Launches $299 Introductory Wegovy® Bundle for Self-Pay Patients in Collaboration with Novo Nordisk

by Jasmine Pennic 05/22/2025 Leave a Comment

LifeMD Launches $299 Introductory Wegovy® Bundle for Self-Pay Patients in Collaboration with Novo Nordisk

What You Should Know:  - LifeMD, Inc., a provider of virtual primary care services announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide).  - The comprehensive package includes both the GLP-1 medication and access to LifeMD’s virtual weight management program. The initiative is part of LifeMD's collaboration with Novo Nordisk, announced last month, and leverages a recently completed integration with NovoCare® Pharmacy to offer
Read More

Medtronic to Separate Diabetes Business into New Standalone Company

by Jasmine Pennic 05/21/2025 Leave a Comment

Medtronic to Separate Diabetes Business into New Standalone Company

What You Should Know:  - Medtronic today announced its strategic decision to separate its Diabetes business into a new, independent, publicly traded company ("New Diabetes Company").  - The move aims to create a more focused Medtronic, with a simplified portfolio concentrated on high-margin growth markets, while simultaneously establishing a scaled, independent leader in the diabetes sector. - The separation is expected to be completed within 18 months through a series of
Read More

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

by Jasmine Pennic 04/30/2025 Leave a Comment

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

What You Should Know:  - Abbott, a provider of continuous glucose monitoring (CGM) biowearable technology, has announced a landmark agreement with Epic Systems, a major provider of electronic health records (EHR).  - The first-of-its-kind collaboration for Abbott will integrate patient glucose data from its leading FreeStyle Libre CGM systems directly into Epic's EHR platform across the United States. FreeStyle Libre Integration with Epic Aura The integration leverages
Read More

Sequel twiist AID System to Integrate with Senseonics Eversense 365 One-Year CGM

by Jasmine Pennic 04/30/2025 Leave a Comment

Sequel twiist AID System to Integrate with Senseonics Eversense 365 One-Year CGM

What You Should Know:  - Sequel Med Tech, LLC, known for its innovative insulin delivery technology, and Senseonics Holdings, Inc., developer of long-term implantable continuous glucose monitoring (CGM) systems, announced a significant commercial development agreement.  - The collaboration will integrate Sequel's twiist™ Automated Insulin Delivery (AID) System, powered by Tidepool, with Senseonics' Eversense® 365 CGM system. This partnership marks a notable advancement in diabetes
Read More

Eli Lilly’s Oral GLP-1 Shows Positive Trial Results for Type 2 Diabetes

by Jasmine Pennic 04/17/2025 Leave a Comment

Lilly's Oral GLP-1 Shows Positive Phase 3 Results for Type 2 Diabetes

What You Should Know:  - Eli Lilly and Company announced positive topline Phase 3 results from ACHIEVE-1, a study evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes whose blood sugar was inadequately controlled through diet and exercise alone.  - Orforglipron stands out as the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3
Read More

FDA Clears Dexcom G7 15 Day Continuous Glucose Monitoring System

by Jasmine Pennic 04/10/2025 Leave a Comment

FDA Clears Dexcom G7 15 Day Continuous Glucose Monitoring System

What You Should Know:  - Dexcom, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for individuals over the age of 18 with diabetes.   - The Dexcom G7 15 Day system boasts an overall Mean Absolute Relative Difference (MARD) of 8.0% and builds upon the proven performance of Dexcom CGM technology, which has been clinically demonstrated to lower A1C, reduce hyper- and hypoglycemia, and
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 21
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |